Concepedia

Riccardo Marconcini

RM

Statistics

Publications

36

Citations

2.9K

H-Index

23

Active since

2013

Affiliations

Istituti di Ricovero e Cura a Carattere Scientifico(Current)

European Institute of Oncology

Azienda Ospedaliera Universitaria Pisana

Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"

Sapienza University of Rome

Riccardo Marconcini is an author at Istituti di Ricovero e Cura a Carattere Scientifico specializing in medicine, oncology, and cancer research.

ORCID

Top concepts

Publications per year

2013–2024

36

Publications

36

A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable

Alessio Cortellini, Melissa Bersanelli, Sebastiano Buti et al. · Journal for ImmunoTherapy of Cancer · 2019 · 400 citations · Full text

Serum lactate dehydrogenase as an early marker for outcome in patients treated with anti-PD-1 therapy in metastatic melanoma

Stefan Diem, Benjamin Kasenda, Lavinia Spain et al. · British Journal of Cancer · 2016 · 304 citations · Full text

Integrated analysis of concomitant medications and oncological outcomes from PD-1/PD-L1 checkpoint inhibitors in clinical practice

Alessio Cortellini, Marco Tucci, Vincenzo Adamo et al. · Journal for ImmunoTherapy of Cancer · 2020 · 250 citations · Full text

PD-L1 mRNA expression in plasma-derived exosomes is associated with response to anti-PD-1 antibodies in melanoma and NSCLC

Marzia Del Re, Riccardo Marconcini, G. Pasquini et al. · British Journal of Cancer · 2018 · 242 citations · Full text

Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study

Alessio Cortellini, Sebastiano Buti, Daniele Santini et al. · The Oncologist · 2019 · 214 citations · Full text

, , +21

1–5 of 36